It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: bigfatfurrytexan
a reply to: seeker1963
The "side effects" thing is kind of a misnomer required by the FDA. Example: i take Humira. One of its side effects is a rare form of lymphoma.
It happened 1 time in trials. SO now its listed as a side effect. The dude probably already had it.
originally posted by: underwerks
I never understood the point of prescription drug commercials. Most of the time if you show knowledge of drugs or pharmacology when discussing with your doctor what treatments would be best for you, you get labeled a drug seeker. And that gets emblazoned on your medical records which causes doctors to not treat you the same as everyone else.
Where are the people who just bring up drugs they'd like to try with their doctor? Is that even a thing?
originally posted by: seeker1963
originally posted by: bigfatfurrytexan
a reply to: seeker1963
The "side effects" thing is kind of a misnomer required by the FDA. Example: i take Humira. One of its side effects is a rare form of lymphoma.
It happened 1 time in trials. SO now its listed as a side effect. The dude probably already had it.
I don't consider death should be an acceptable side effect do you? Maybe for a patient who is going to die regardless, but not for a patient who still has a few years left?
...the simple fact is that non-medical people aren't knowledgeable enough about diseases and medications to make these kinds of judgements. Marketing directly to them is straight up unethical.
A lot of times it is just brand recognition. In many cases, it is actually advertising to doctors in an indirect way. I think the Pharma companies are trying to get patients to ask their doctors more than anything.
originally posted by: underwerks
a reply to: Edumakated
A lot of times it is just brand recognition. In many cases, it is actually advertising to doctors in an indirect way. I think the Pharma companies are trying to get patients to ask their doctors more than anything.
Indirectly marketing to doctors makes sense. I've just always thought it was weird that most of the prescription drug commercials end with "Talk to your doctor today about trying our new drug!"
Like people are just going to go into their doctors office and ask to try a new drug they saw on TV. That's how you end up on a list. Lmao.
originally posted by: underwerks
a reply to: Edumakated
A lot of times it is just brand recognition. In many cases, it is actually advertising to doctors in an indirect way. I think the Pharma companies are trying to get patients to ask their doctors more than anything.
Indirectly marketing to doctors makes sense. I've just always thought it was weird that most of the prescription drug commercials end with "Talk to your doctor today about trying our new drug!"
Like people are just going to go into their doctors office and ask to try a new drug they saw on TV. That's how you end up on a list. Lmao.
originally posted by: seeker1963
originally posted by: bigfatfurrytexan
a reply to: seeker1963
The "side effects" thing is kind of a misnomer required by the FDA. Example: i take Humira. One of its side effects is a rare form of lymphoma.
It happened 1 time in trials. SO now its listed as a side effect. The dude probably already had it.
I don't consider death should be an acceptable side effect do you? Maybe for a patient who is going to die regardless, but not for a patient who still has a few years left?
Deep-pocketed pharmaceutical companies argued that patients have a right to know all their options and that pitching prescription drugs on TV thus would benefit the public (and, coincidentally, boost sales). Regulators eventually bowed to industry pressure.
The impact was immediate. Spending by drug companies on TV ads hit $664 million within a year. By 2005, the industry was spending more than $3 billion annually on televised DTC ads. The figure nowadays tops $5 billion.
Is this a good thing? The pharmaceutical industry thinks so. DTC ads increase sales and steer patients away from cheaper generic alternatives.
Nevertheless, the drug industry is now seeking official approval to expand its DTC efforts by also promoting so-called off-label drug uses — that is, uses for which a drug wasn't originally intended and for which it may not be fully tested. An FDA spokeswoman told me a policy change is under consideration.
The power of suggestion is very strong.